Page 59 - Quest Diagnostics News Today

Last year, the first blood test for assessing beta amyloid protein was made available for consumer purchase in the United States, called AD-Detect, to help people with mild cognitive impairment

Testing a person’s blood for a type of protein called phosphorylated tau, or p-tau, could be used to screen for Alzheimer’s disease with “high accuracy,” even before symptoms begin to show, a new study suggests.

The study included data on 786 people, who had an average age of 66 and had brain scans and spinal taps completed, as well as blood samples collected.

Testing a person’s blood for a type of protein called phosphorylated tau, or p-tau, could be used to screen for Alzheimer’s disease with “high accuracy,” even before symptoms begin to show, a new study suggests.

The study included data on 786 people, who had an average age of 66 and had brain scans and spinal taps completed, as well as blood samples collected.

The study included data on 786 people, who had an average age of 66 and had brain scans and spinal taps completed, as well as blood samples collected.

(CNN) — Testing a person’s blood for a type of protein called phosphorylated tau, or p-tau, could be used to screen for Alzheimer’s disease with “high accuracy,” even before symptoms

The study included data on 786 people, who had an average age of 66 and had brain scans and spinal taps completed, as well as blood samples collected.

The study included data on 786 people, who had an average age of 66 and had brain scans and spinal taps completed, as well as blood samples collected.

The study included data on 786 people, who had an average age of 66 and had brain scans and spinal taps completed, as well as blood samples collected.